Better outcomes for depressive disorders?
ثبت نشده
چکیده
Well conducted investigations into the long-term outcome of depressive disorders are rare. This issue of Psychological Medicine publishes two important papers reporting on different cohorts of depressed patients, one series from Japan (Kanai et al. 2003) and the other from Cambridge UK (Kennedy et al. 2003). Both were ascertained in the early 1990s and have been followed for 5–6 and 8–10 years respectively. Each study demonstrates methodological advances. Both invite comparison with previous reports of the long-term outcome of depression whose follow-up periods span the last 40 years. Is the outcome of depressive disorders at last improving in the era of modern treatments? Is this merely an artefact of better research methods, or does it also reflect therapeutic advances? If there has been very little improvement in some aspects of outcome, what lessons can we learn for future research and practice development?
منابع مشابه
روابط ساختاری ابعاد شخصیتی نئو با نشانههای اختلالهای اضطرابی و افسردگی
Objectives: The aim of this study was to determine common and specific factors of anxiety and depressive disorders based on the NEO personality dimensions. Method: Four hundred and thirteen students of Tabriz University (200 males, 213 females) selected by cluster sampling responded to the following questionnaires: NEO Five-Factor Inventory (NEO-FFI), Beck Depression Inventory-II (BDI-II), Anxi...
متن کامل5-Hydroxy tryptamine transporter (5HTT) gene promoter region polymorphism in anxiety and depressive disorders
Background :5HTTLPR polymorphism (5- Hydroxytryptamine transporter linked promoter region polymorphism) is the most widely studied genetic variant in psychiatry. The present study is a modest effort at ascertaining the role of 5HT transporter linked promoter region polymorphism (5HTTLPR) in anxiety and depressive disorders in Kashmir (India).The aim of this study was to examine 5-Hydroxy tryp...
متن کاملEconomic evaluation of resistant major depressive disorder treat-ment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive
Background: It is estimated that major depression disorders constitute 8.2% of years lived with disability (YLDs) globally. The repetitive Transcranial Magnetic Stimulation (rTMS) and Electroconvulsive Therapy (ECT) are two relative common interventions to treat major depressive disorders, especially for treatment resistant depression. In this study the cost- effectiveness and cost-utility of r...
متن کاملتعیین ارتباط دیابت و افسردگی در بیماران دیابتی مراجعه کننده به درمانگاه دیابت بیمارستان دکتر شریعتی و انجمن دیابت ایران
Depression is one of the most prevalent mental disorders in diabetics, which affects treatment course and disease prognosis. This study focuses on the association between diabetes and depression as well as depression and glycemic control.Methods: 375 diabetic patients (type I and II) of diabetes clinic of Doctor Shariati Hospital and diabetes association of Iran participated in this cross-secti...
متن کاملA Comparison of Emotional Schemas in Patients with Bipolar Disorders and Major Depressive Disorder in Remission and Nonclinical Population
Objective: Similarities and differences among mood disorders can help psychiatrics in their exact diagnosis and more effective treatments. Therefore, the current research sought to identify differences between patients with bipolar disorder, major depressive disorder, and nonclinical group in emotional schemas. Methods: The present research was a cross-sectional study. The research sample cons...
متن کاملDepression outcome in alcohol dependent patients: an evaluation of the role of independent and substance-induced depression and other predictors.
BACKGROUND Depression commonly co-occurs with alcohol use disorders but predictors of depression treatment outcome in patients with both conditions are not well established. METHODS Outpatients with alcohol dependence and major depression (n=138) were prescribed naltrexone and randomized to citalopram or placebo for 12 weeks, followed by a 12-week naturalistic outcome phase. General linear mi...
متن کامل